Melazyme Raises $2M Seed Round Led by SeaX Ventures

Why It Matters

The funding validates precision fermentation’s expansion beyond dairy proteins into high‑value biomolecules, promising faster, greener supply chains for multiple industries.

Key Takeaways

• Melazyme secured $2M seed funding for fermentation platform.
• Produces melanin >99% purity, surpassing natural extraction.
• Targets cosmetics, filtration, heavy‑metal cleanup, rare‑earth recovery.
• Co‑founders previously built Perfect Day’s precision‑fermentation business.
• Investors cite broad market scope and tunable molecule technology.

Pulse Analysis

Precision fermentation has moved from niche dairy alternatives to a versatile bio‑manufacturing engine, and Melazyme’s latest raise underscores that shift. Backed by a team that helped launch Perfect Day, the Utah startup leverages a patent‑pending platform that can fine‑tune molecular characteristics at scale. By delivering melanin with more than 99% purity—a stark improvement over traditional cuttlefish extraction—the company addresses a long‑standing supply bottleneck that has limited broader adoption in cosmetics and industrial applications.

Melanin’s unique combination of broadband UV absorption, chemical stability, and affinity for metal ions makes it attractive for diverse markets. In cosmetics, it can replace synthetic pigments while offering natural UV protection; in water treatment, its metal‑binding properties enable efficient heavy‑metal removal and even rare‑earth element recovery. Brazzein, a heat‑stable sweet protein, adds a food‑grade revenue stream, positioning Melazyme as a multi‑sector player. The platform’s ability to engineer functional variants means customers can obtain tailor‑made materials without costly post‑processing, a competitive edge that could accelerate adoption across sectors.

Investors such as SeaX Ventures, Stellaris and Plug and Play see the company’s broad addressable market and the team’s proven execution as key differentiators. Their backing provides not only capital but also strategic connections to global manufacturers, especially in cosmetics where early pilots are already underway. If Melazyme can scale production while maintaining its purity claims, it could set a new benchmark for bio‑derived specialty chemicals, prompting larger incumbents to explore fermentation routes and reshaping supply chains toward more sustainable, high‑performance biomaterials.

Deal Summary

Utah-based precision fermentation startup Melazyme announced the closing of a $2 million seed round, led by Bangkok deep‑tech fund SeaX Ventures with participation from Stellaris Venture Partners and Plug and Play Ventures. The funding will support platform development, production scale‑up, and early commercial deployment of its melanin and brazzein molecules for cosmetics, industrial and environmental applications.